In this context, Inositol hexakisphosphate kinase 1 (IP6K1) has been considered a potential target in treating obesity, metabolic diseases, and more recently bone disorders [48]. The gene discussed is IP6K1; the disease is obesity due to melanocortin 4 receptor deficiency.